Metabolic Syndrome Components and Chronic Kidney Disease in a Community Population Aged 40 Years and Older in Southern China: A Cross-Sectional Study

References

• Zhang L, Zhao MH, Zuo L, et al. China Kidney Disease Network (CK-NET) 2016 annual data report. Kidney Int Suppl. 2020;10(2):e97–e185. doi:10.1016/j.kisu.2020.09.001
   PubMed Web of Science ®Google Scholar
• Murphy D, McCulloch CE, Lin F, et al. Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med. 2016;165(7):473–481. doi:10.7326/M16-0273
   PubMed Web of Science ®Google Scholar
• Jonsson AJ, Lund SH, Eriksen BO, Palsson R, Indridason OS. The prevalence of chronic kidney disease in Iceland according to KDIGO criteria and age-adapted estimated glomerular filtration rate thresholds. Kidney Int. 2020;98(5):1286–1295. doi:10.1016/j.kint.2020.06.017
   Web of Science ®Google Scholar
• Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–822. doi:10.1016/s0140-6736(12)60033-6
   PubMed Web of Science ®Google Scholar
• Glassock RJ, Warnock DG, Delanaye P. The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2017;13(2):104–114. doi:10.1038/nrneph.2016.163
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645. doi:10.1161/CIRCULATIONAHA.109.192644
   PubMed Web of Science ®Google Scholar
• Zhang X, Lerman LO. The metabolic syndrome and chronic kidney disease. Transl Res. 2017;183:14–25. doi:10.1016/j.trsl.2016.12.004
   Web of Science ®Google Scholar
• Ho JS, Cannaday JJ, Barlow CE, Mitchell TL, Cooper KH, FitzGerald SJ. Relation of the number of metabolic syndrome risk factors with all-cause and cardiovascular mortality. Am J Cardiol. 2008;102(6):689–692. doi:10.1016/j.amjcard.2008.05.010
   PubMed Web of Science ®Google Scholar
• Xu H, Kuja-Halkola R, Chen X, Magnusson PKE, Svensson P, Carrero JJ. Higher body mass index is associated with incident diabetes and chronic kidney disease independent of genetic confounding. Kidney Int. 2019;95(5):1225–1233. doi:10.1016/j.kint.2018.12.019
   PubMed Web of Science ®Google Scholar
• Pammer LM, Lamina C, Schultheiss UT, et al. Association of the metabolic syndrome with mortality and major adverse cardiac events: a large chronic kidney disease cohort. J Intern Med. 2021;290(6):1219–1232. doi:10.1111/joim.13355
   Web of Science ®Google Scholar
• Lea JP. Metabolic syndrome, CKD progression, and death: the good, the bad, and the ugly. Clin J Am Soc Nephro. 2013;8(6):893–895. doi:10.2215/CJN.03960413
   Web of Science ®Google Scholar
• Comini LO, de Oliveira LC, Borges LD, et al. Individual and combined components of metabolic syndrome with chronic kidney disease in individuals with hypertension and/or diabetes mellitus accompanied by primary health care. Diabetes Metabol Syndr Obes. 2020;13:71–80. doi:10.2147/DMSO.S223929
   PubMed Web of Science ®Google Scholar
• Yun HR, Kim H, Park JT, et al. Obesity, metabolic abnormality, and progression of CKD. Am J Kidney Dis. 2018;72(3):400–410. doi:10.1053/j.ajkd.2018.02.362
   PubMed Web of Science ®Google Scholar
• Saran R, Robinson B, Abbott KC, et al. US renal data system 2019 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2020;75(1Suppl 1):A6–A7. doi:10.1053/j.ajkd.2019.09.003
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–S266.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2011;80(1):17–28. doi:10.1038/ki.2010.483
   PubMed Web of Science ®Google Scholar
• Cao X, Zhou J, Yuan H, Wu L, Chen Z. Chronic kidney disease among overweight and obesity with and without metabolic syndrome in an urban Chinese cohort. BMC Nephrol. 2015;16:85. doi:10.1186/s12882-015-0083-8
   Web of Science ®Google Scholar
• Zhang L, Zuo L, Wang F, et al. Metabolic syndrome and chronic kidney disease in a Chinese population aged 40 years and older. Mayo Clin Proc. 2007;82(7):822–827. doi:10.4065/82.7.822
   Web of Science ®Google Scholar
• Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140(3):167–174. doi:10.7326/0003-4819-140-3-200402030-00007
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun B, Sheng LT, et al. Association between weight status, metabolic syndrome, and chronic kidney disease among middle-aged and elderly Chinese. Nutr Metab Cardiovasc Dis. 2020;30(11):2017–2026. doi:10.1016/j.numecd.2020.06.025
   PubMed Web of Science ®Google Scholar
• Evangelista LS, Cho WK, Kim Y. Obesity and chronic kidney disease: a population-based study among South Koreans. PLoS One. 2018;13(2):e0193559. doi:10.1371/journal.pone.0193559
   PubMed Web of Science ®Google Scholar
• Garofalo C, Borrelli S, Minutolo R, Chiodini P, De Nicola L, Conte G. A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. Kidney Int. 2017;91(5):1224–1235. doi:10.1016/j.kint.2016.12.013
   PubMed Web of Science ®Google Scholar
• Xie K, Bao L, Jiang X, et al. The association of metabolic syndrome components and chronic kidney disease in patients with hypertension. Lipids Health Dis. 2019;18(1):229. doi:10.1186/s12944-019-1121-5
   PubMed Web of Science ®Google Scholar
• Maeda T, Yoshimura C, Takahashi K, et al. Usefulness of the blood pressure classification in the new 2017 ACC/AHA hypertension guidelines for the prediction of new-onset chronic kidney disease. J Hum Hypertens. 2019;33(12):873–878. doi:10.1038/s41371-019-0198-7
   Web of Science ®Google Scholar
• Shi W, Wang H, Zhou Y, Sun Y, Chen Y. Synergistic interaction of hyperuricemia and hypertension on reduced eGFR: insights from a general Chinese population. Postgrad Med. 2020;132(3):263–269. doi:10.1080/00325481.2020.1718387
   PubMed Web of Science ®Google Scholar
• Lin L, Lu J, Chen L, et al. Glycemic status and chronic kidney disease in Chinese adults: findings from the REACTION study. J Diabetes. 2017;9(9):837–845. doi:10.1111/1753-0407.12490
   Web of Science ®Google Scholar
• Duan J, Wang C, Liu D, et al. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross-sectional survey. Sci Rep. 2019;9(1):10408. doi:10.1038/s41598-019-46857-7
   PubMed Web of Science ®Google Scholar
• Spoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Renal Physiol. 2016;311(6):F1087–F1108. doi:10.1152/ajprenal.00340.2016
   PubMed Web of Science ®Google Scholar
• Jabarpour M, Rashtchizadeh N, Argani H, et al. The impact of dyslipidemia and oxidative stress on vasoactive mediators in patients with renal dysfunction. Int Neurol Nephrol. 2019;51(12):2235–2242. doi:10.1007/s11255-019-02319-7
   PubMed Web of Science ®Google Scholar
• Bulbul MC, Dagel T, Afsar B, et al. Disorders of lipid metabolism in chronic kidney disease. Blood Purif. 2018;46(2):144–152. doi:10.1159/000488816
   PubMed Web of Science ®Google Scholar
• Trevisan R, Dodesini AR, Lepore G. Lipids and renal disease. J Am Soc Nephrol. 2006;17(4 Suppl 2):S145–7. doi:10.1681/ASN.2005121320
   PubMed Web of Science ®Google Scholar
• Miljkovic M, Stefanovic A, Simic-Ogrizovic S, et al. Association of dyslipidemia, oxidative stress, and inflammation with redox status in VLDL, LDL, and HDL lipoproteins in patients with renal disease. Angiology. 2018;69(10):861–870. doi:10.1177/0003319718780041
   PubMed Web of Science ®Google Scholar
• Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72(3):247–259. doi:10.1038/sj.ki.5002343
   PubMed Web of Science ®Google Scholar